StockData
IQVIA Holdings Inc. logo

IQVIA Holdings Inc. (IQV) stock

IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3013% above fair value
$245.82−4.73 (-1.89%)

Close on Nov 20, 2026Market cap $40.51BP/E 29.9Yield –

Iqvia net income

Net income is the profit left for shareholders after every expense, interest and tax.

Iqvia's net income for the twelve months ending Sep 30, 2026 was $1.39B, up 8.7% year over year. For fiscal 2025 it was $1.36B, down 0.9% from the year before. Over ten years it grew 13.4% a year on average. The highest annual figure on record is $1.37B in fiscal 2024.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.36B-0.9%
FY2024Dec 31, 2024$1.37B+1.1%
FY2023Dec 31, 2023$1.36B+24.5%
FY2022Dec 31, 2022$1.09B+12.9%
FY2021Dec 31, 2021$966.00M+246.2%
FY2020Dec 31, 2020$279.00M+46.1%
FY2019Dec 31, 2019$191.00M-26.3%
FY2018Dec 31, 2018$259.00M-79.7%
FY2017Dec 31, 2017$1.28B+1673.6%
FY2016Dec 31, 2016$72.00M-81.4%
FY2015Dec 31, 2015$387.00M+8.4%
FY2014Dec 31, 2014$357.00M+57.6%
FY2013Dec 31, 2013$226.59M+27.6%
FY2012Dec 31, 2012$177.55M-26.6%
FY2011Dec 31, 2011$241.77M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$350.00M+5.7%
Q2 FY2026Jun 30, 2026$256.00M-3.8%
Q1 FY2026Mar 31, 2026$274.00M+10.0%
Q4 FY2025Dec 31, 2025$514.00M+17.6%
Q3 FY2025Sep 30, 2025$331.00M+16.1%
Q2 FY2025Jun 30, 2025$266.00M-26.7%
Q1 FY2025Mar 31, 2025$249.00M-13.5%
Q4 FY2024Dec 31, 2024$437.00M-6.8%
Q3 FY2024Sep 30, 2024$285.00M-5.9%
Q2 FY2024Jun 30, 2024$363.00M+22.2%
Q1 FY2024Mar 31, 2024$288.00M-0.3%
Q4 FY2023Dec 31, 2023$469.00M+106.6%
Q3 FY2023Sep 30, 2023$303.00M+7.1%
Q2 FY2023Jun 30, 2023$297.00M+16.0%
Q1 FY2023Mar 31, 2023$289.00M-11.1%
Q4 FY2022Dec 31, 2022$227.00M-28.6%
Q3 FY2022Sep 30, 2022$283.00M+8.4%
Q2 FY2022Jun 30, 2022$256.00M+46.3%
Q1 FY2022Mar 31, 2022$325.00M+53.3%
Q4 FY2021Dec 31, 2021$318.00M+167.2%
Q3 FY2021Sep 30, 2021$261.00M+158.4%
Q2 FY2021Jun 30, 2021$175.00M–
Q1 FY2021Mar 31, 2021$212.00M+158.5%
Q4 FY2020Dec 31, 2020$119.00M+643.8%
Q3 FY2020Sep 30, 2020$101.00M+77.2%
Q2 FY2020Jun 30, 2020-$23.00M-138.3%
Q1 FY2020Mar 31, 2020$82.00M+41.4%
Q4 FY2019Dec 31, 2019$16.00M-76.8%
Q3 FY2019Sep 30, 2019$57.00M-5.0%
Q2 FY2019Jun 30, 2019$60.00M-1.6%
Q1 FY2019Mar 31, 2019$58.00M-15.9%
Q4 FY2018Dec 31, 2018$69.00M-93.3%
Q3 FY2018Sep 30, 2018$60.00M-31.8%
Q2 FY2018Jun 30, 2018$61.00M-1.6%
Q1 FY2018Mar 31, 2018$69.00M-31.0%
Q4 FY2017Dec 31, 2017$1.03B–
Q3 FY2017Sep 30, 2017$88.00M–
Q2 FY2017Jun 30, 2017$62.00M–
Q1 FY2017Mar 31, 2017$100.00M–
Q4 FY2016Dec 31, 2016-$178.00M–

More Iqvia figures

See a number that looks wrong?